The FTC Wants to Block the $28 Billion Amgen-Horizon Therapeutics Deal

The Federal Trade Commission and its hard-nosed chair Lina Khan have struck again, this time filing a lawsuit in federal court on Tuesday to halt biotech giant Amgen’s $28 billion blockbuster acquisition of Horizon Therapeutics. Consider it a black box warning for the industry’s M&A-dependent…#linakhan #amgen #horizontherapeutics #ftc #phd #horizon #hollyvedova #wellsfargo #pfizer #merck
Source: Reuters: Health - Category: Consumer Health News Source Type: news